Ocumension Therapeutics 3
3 · ALIMERA SCIENCES INC · Filed Apr 30, 2021
Insider Transaction Report
Form 3
Ocumension Therapeutics
10% Owner
Holdings
- 1,144,945
Common Stock, $.01 par value
[F1]
Footnotes (1)
- [F1]The reported securities are directly owned by Ocumension Therapeutics.
Signature
/s/ Ye Liu as authorized signatory|2021-04-30